ArticleCurrent oncology (Toronto, Ont.)2025

TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization.

Ken Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.